Healthcare institutions face widespread challenges of delivering high-quality and cost-effective care, while keeping up with rapid advances in biomedical knowledge and technologies. Moreover, there is increased emphasis on developing personalized or precision medicine targeted to individuals or groups of patients who share a certain biomarker signature. Learning healthcare systems (LHS) have been proposed for integration of research and clinical practice to fill major knowledge gaps, improve care, reduce healthcare costs, and provide precision care. To date, much discussion in this context has focused on the potential of human genomic data, and not yet on human microbiome data. Rapid advances in human microbiome research suggest that profiling of, and interventions on, the human microbiome can provide substantial opportunity for improved diagnosis, therapeutics, risk management, and risk stratification. In this study, we discuss a potential role for microbiome science in LHSs. We first review the key elements of LHSs, and discuss possibilities of Big Data and patient engagement. We then consider potentials and challenges of integrating human microbiome research into clinical practice as part of an LHS. With rapid growth in human microbiome research, patient-specific microbial data will begin to contribute in important ways to precision medicine. Hence, we discuss how patient-specific microbial data can help guide therapeutic decisions and identify novel effective approaches for precision care of inflammatory bowel disease. To the best of our knowledge, this expert analysis makes an original contribution with new insights poised at the emerging intersection of LHSs, microbiome science, and postgenomics medicine.
Get full access to this article
View all access options for this article.
References
1.
AlbenbergLG, and WuGD. (2014). Diet and the intestinal microbiome: Associations, functions, and implications for health and disease. Gastroenterology, 146, 1564–1572.
2.
AmreDK, D'SouzaS, MorganK, et al. (2007). Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol, 102, 2016–2025.
3.
AnanthakrishnanAN, KhaliliH, KonijetiGG, et al. (2014). Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut, 63, 776–784.
4.
AngristM, and JamalL. (2015). Living laboratory: Whole-genome sequencing as a learning healthcare enterprise. Clin Genet, 87, 311–318.
5.
AronsonSJ, and RehmHL. (2015). Building the foundation for genomics in precision medicine. Nature, 526, 336–342.
6.
BernsteinJA, FriedmanC, JacobsonP, and RubinJC. (2015). Ensuring public health's future in a national-scale learning health system. Am J Prev Med, 48, 480–487.
7.
CarterP, LaurieGT, and Dixon-WoodsM. (2015). The social licence for research: Why care.data ran into trouble. J Med Ethics, 41, 404–409.
8.
Chapman-KiddellCA, DaviesPSW, GillenL, and Radford-SmithGL. (2010). Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis, 16, 137–151.
9.
CoburnB, WangPW, CaballeroJD, et al. (2015). Lung microbiota across age and disease stage in cystic fibrosis. Scientific Reports, 5, 10241.
CosteaI, MackDR, IsraelD, et al. (2010). Genes involved in the metabolism of poly-unsaturated fatty-acids (PUFA) and risk for Crohn's disease in children & young adults. PLoS One, 5, e15672.
12.
Dominguez-BelloMG, De Jesus-LaboyKM, ShenN, et al. (2016). Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med, 22, 250–253.
13.
FadenRR, KassNE, GoodmanSN, PronovostP, TunisS, and BeauchampTL. (2013). An ethics framework for a learning health care system: A departure from traditional research ethics and clinical ethics. Hastings Cent Rep, 43, S16–S27.
14.
FiererN, LauberCL, ZhouN, McDonaldD, CostelloEK, and KnightR. (2010). Forensic identification using skin bacterial communities. Proc Natl Acad Sci U S A, 107, 6477–6481.
15.
ForrestCB, CrandallWV, BaileyC, et al. (2014). Effectiveness of anti-TNFα for Crohn disease: Research in a pediatric learning health system. Pediatrics, 134, 37–44.
16.
FriedmanCP, WongAK, and BlumenthalD. (2010). Achieving a nationwide learning health system. Sci Transl Med, 2, 57cm29.
17.
FriedmanCP, RubinJ, BrownJ, et al. (2015). Toward a science of learning systems: A research agenda for the high-functioning learning health system. J Am Med Inform Assoc, 22, 43–50.
18.
FujimuraKE, and LynchSV. (2015). Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe, 17, 592–602.
19.
GreeneSM, ReidRJ, and LarsonEB. (2012). Implementing the learning health system: From concept to action. Ann Intern Med, 157, 207–210.
20.
HamptonTH, GreenDM, CuttingGR, et al. (2014). The microbiome in pediatric cystic fibrosis patients: The role of shared environment suggests a window of intervention. Microbiome, 2, 14.
21.
HawkinsAK, and O'DohertyKC. (2011). “Who owns your poop?” Insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Med Genomics, 4, 72.
22.
HoffmannDE, FortenberryJD, and RavelJ. (2013). Are changes to the Common Rule necessary to address evolving areas of research? A case study focusing on the Human Microbiome Project. J Law Med Ethics, 41, 454–469.
23.
HouJK, LeeD, and LewisJ. (2014). Diet and inflammatory bowel disease: Review of patient-targeted recommendations. Clin Gastroenterol Hepatol, 12, 1592–1600.
24.
Institute of Medicine, Committee on the Learning Health Care System in . (2013). Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: National Academies Press.
25.
JamesonJL, and LongoDL. (2015). Precision medicine–personalized, problematic, and promising. N Engl J Med, 372, 2229–2234.
26.
KelleyM, JamesC, KraftSA, et al. (2015). Patient perspectives on the learning health system: The importance of trust and shared decision making. Am J Bioeth, 15, 4–17.
27.
KolevaPT, BridgmanSL, and KozyrskyjAJ. (2015). The infant gut microbiome: Evidence for obesity risk and dietary intervention. Nutrients, 7, 2237–2260.
28.
KostkovaP, BrewerH, de LusignanS, et al. (2016). Who owns the data? Open data for healthcare. Front Public Health, 4, 7.
29.
KosticAD, XavierRJ, and GeversD. (2014). The microbiome in inflammatory bowel disease: Current status and the future ahead. Gastroenterology, 146, 1489–1499.
30.
KrumholzHM. (2014). Big data and new knowledge in medicine: The thinking, training, and tools needed for a learning health system. Health Aff, 33, 1163–1170.
31.
LewisJD, ChenEZ, BaldassanoRN, et al. (2015). Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe, 18, 489–500.
32.
McGuireAL, AchenbaumLS, WhitneySN, et al. (2012). Perspectives on human microbiome research ethics. J Empir Res Hum Res Ethics, 7, 1–14.
33.
ModyRJ, WuYM, LonigroRJ, et al. (2015). Integrative clinical sequencing in the management of refractory or relapsed cancer in youth. J Am Med Inform Assoc, 314, 913–925.
34.
MolodeckyNA, SoonIG, RabiDM, et al. (2012). Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 142, 46–54.
35.
O'DohertyKC, BurgessMM, EdwardsK, et al. (2011). From consent to institutions: Designing adaptive governance for genomic biobanks. Soc Sci Med, 73, 367–374.
36.
PresserL, HruskovaM, RowbottomH, and KancirJ. (2015). Care.data and access to UK health records: Patient privacy and public trust. Technology Science. http://techscience.org/a/2015081103. Accessed January18, 2017.
37.
PsekWA, StametzRA, Bailey-DavisLD, et al. (2015). Operationalizing the learning health care system in an integrated delivery system. eGEMs, 3, 6.
38.
PsekWA, DavisFD, GerrityG, et al. (2016). Leadership perspectives on operationalizing the learning health care system in an integrated delivery system. eGEMs, 4, 6.
39.
RhodesR, GligorovN, and SchwabAP. (Eds) (2013). The Human Microbiome: Ethical, Legal and Social Concerns. New York, NY: Oxford University Press.
40.
RobinsonD, Van AllenEM, WuYM, et al. (2015). Integrating clinical genomics of advanced prostate cancer. Cell, 161, 1215–1228.
41.
RuemmeleFM, VeresG, KolhoKL, et al. (2014). Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis, 8, 1179–1207.
42.
SartorRB, and MazmanianSK. (2012). Intestinal microbes in inflammatory bowel diseases. Am J Gastroenterol Supplements, 1, 15–21.
43.
SchilskyRL, MichelsDL, KearbeyAH, YuPP, and HudisCA. (2014). Building a rapid learning health care system for oncology: The regulatory framework of CancerLinQ. J Clin Oncol, 32, 2372–2379.
44.
ShirtBH, SalamaJS, AronsonSJ, et al. (2015). CSER and eMERGE: Current and potential state of the display of genetic information in the electronic health record. J Am Med Inform Assoc, 22, 1231–1242.
45.
SlashinskiMJ, McCurdySA, AchenbaumLS, WhitneySM, and McGuireAL. (2012). “Snake-oil,” “quack medicine,” and “industrially cultured organisms”: Biovalue and the commercialization of human microbiome research. BMC Med Ethics, 13, 28.
46.
StarrAE, DeekeSA, NingZ, et al. (2016). Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC. Gut. (in press).
47.
SterckxS, RakicV, CockbainJ, and BorryP. (2016). “You hoped we would sleep walk into accepting the collection of our data”: Controversies surrounding the UK care.data scheme and their wider relevance for biomedical research. Med Health Care Philos, 19, 177–190.
48.
StulbergE, FravelD, ProctorLM, et al. (2016). An assessment of US microbiome research. Nat Microbiol, 1, 15015.
WingleeK, and FodorAA. (2015). Intrinsic association between diet and the gut microbiome: Current evidence. Nutr Diet Suppl, 7, 69–76.
53.
ZhangX, NingZ, MayneJ, et al. (2016a). In Vitro metabolic labelling of intestinal microbiota for quantitative metaproteomics. Anal Chem, 88, 6120–6125.
54.
ZhangX, NingZ, MayneJ, et al. (2016b). MetaPro-IQ: A universal metaproteomic approach to studying human and mouse gut microbiota. Microbiome, 4, 31.
55.
ZmoraN, ZeeviD, KoremT, SegalE, and ElinavE. (2016). Taking it personally: Personalized utilization of the human microbiome in health and disease. Cell Host Microbe, 19, 12–20.
